In summary, anti-apoptotic and cardioprotective effects of ATOR in HG-treated cardiomyocytes and in DCM were partially dependent on regulating GSK-3β-PP2Ac-NF-κB signaling. The gene discussed is NFKB1; the disease is familial dilated cardiomyopathy.